Efficacy and safety of Remdesivir in Indian patients with moderate to severe COVID-19: Results from the open label period of a phase II, randomized controlled trial - Current Issue

Efficacy and safety of Remdesivir in Indian patients with moderate to severe COVID-19: Results from the open label period of a phase II, randomized controlled trial - Current Issue - IJSR